Return to Publications
March 2018
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.
Arap and Pasqualini

Rutgers Cancer Institute of New Jersey at University Hospital Expands Oncology Leadership

New oncology leaders for Rutgers Cancer Institute of New Jersey at University Hospital in Newark have been named, further enhancing the facility's expertise and ability to deliver National Cancer Institute-designated Comprehensive Cancer Center services to the greater Essex County region. Wadih Arap, MD, PhD is the new director for Rutgers Cancer Institute of New Jersey at University Hospital and Renata Pasqualini, PhD is the new chief of the Division of Cancer Biology in the Department of Radiation Oncology at Rutgers Cancer Institute and Rutgers New Jersey Medical School. Both previously held leadership roles at the University of New Mexico Comprehensive Cancer Center.

H. Richard Alexander, Jr., MD, FACS

Turning Up the Heat on Chemotherapy

A unique combination of traditional therapies can provide benefit for some cancer patients with difficult to treat tumors. Rutgers Cancer Institute of New Jersey Chief Surgical Officer, H. Richard Alexander, Jr., MD, FACS, professor of surgery at Rutgers Robert Wood Johnson Medical School, shares more about an approach combining cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for cancers that have spread to the abdominal cavity - a condition known as peritoneal metastases. Rutgers Cancer Institute is one of a few centers in the region whose surgeons have vast expertise in managing patients' disease through this unique treatment.

Top Docs Women's Health

Rutgers Cancer Institute Doctors Named 'Tops' in Women's Health

Several physicians at Rutgers Cancer Institute of New Jersey have earned recognition as a 'Top Doctor for Women's Health' by Inside Jersey magazine, which recently released its annual listing. Under the direction of Castle Connolly Medical Ltd., which publishes America's Top Doctors, peer nominations were reviewed and assessed by a physician-led research team. Attributes considered include board certification, medical education, training, hospital appointments, years in practice and professional achievements.

Go BLUE NJ

Colorectal Cancer Research and Prevention: Innovation, Progress and Promise

Innovation and progress in cancer research and care are the result of collaboration and resources. This advancement also extends to cancer prevention and education, but more emphasis on these areas is needed. This especially is the case when it comes to colorectal cancer, which will strike an additional 4,000 New Jersey residents this year according to the American Cancer Society. The directors of both Rutgers Cancer Institute of New Jersey and Rutgers Cancer Institute of New Jersey at University Hospital discuss the need for integrated care and enhancement of cancer education, outreach and screening efforts. These efforts are part of ScreenNJ, a collaborative project led by Rutgers Cancer Institute involving organizations across the state committed to reducing cancer incidence and mortality through an effective cancer prevention and screening program. The centers are also joining forces with #GOBLUENJ, a statewide effort to raise awareness of the importance of colon cancer screening.